MedTrace Logo

Evaluation of Potential Allergenicity of New Wheat Varieties

NCT02341040 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2018-05-21

No results posted yet for this study

Summary

The goal of the study is to determine accurate blood test levels that can predict whether or not subjects are truly allergic to certain foods. In this study, subjects that are clinically documented to be wheat-allergic will participate in a double blind oral food challenge. Blood will be collected from the subject to evaluate the potential allergenicity of proteins introduced into genetically modified crops and evaluate wheat-specific immunoglobulin-e (IgE) antibody reactivity to biotech and conventional wheat varieties.

Conditions

Sponsors & Collaborators

  • Monsanto Company, LLC

    collaborator INDUSTRY

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • David Fleischer, MD · University of Colorado, Denver

Eligibility

Min Age
1 Year
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2018-05-15
Completion
2018-05-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02341040 on ClinicalTrials.gov